Aaron Cravens

Aaron Cravens is currently the Chief Executive Officer at Revel Pharmaceuticals since September 2019. Prior to this, Aaron also worked as a consultant at xCella Biosciences and Antheia, Inc. Aaron also interned at Google. Aaron holds a PhD in Biological/Biosystems Engineering from Stanford University and a Bachelor of Science in Mathematics from the University of Rochester.